The DOI matches its Crossref record; 277 of the 277 references it cites were found in a registry or an index.
Alzheimer's disease: Targeting the Cholinergic System
Open accessAbstract
Acetylcholine (ACh) has a crucial role in the peripheral and central nervous systems. The enzyme choline acetyltransferase (ChAT) is responsible for synthesizing ACh from acetyl-CoA and choline in the cytoplasm and the vesicular acetylcholine transporter (VAChT) uptakes the neurotransmitter into synaptic vesicles. Following depolarization, ACh undergoes exocytosis reaching the synaptic cleft, where it can bind its receptors, including muscarinic and nicotinic receptors. ACh present at the synaptic cleft is promptly hydrolyzed by the enzyme acetylcholinesterase (AChE), forming acetate and choline, which is recycled into the presynaptic nerve terminal by the high-affinity choline transporter (CHT1). Cholinergic neurons located in the basal forebrain, including the neurons that form the nucleus basalis of Meynert, are severely lost in Alzheimer's disease (AD). AD is the most ordinary cause of dementia affecting 25 million people worldwide. The hallmarks of the disease are the accumulation of neurofibrillary tangles and amyloid plaques. However, there is no real correlation between levels of cortical plaques and AD-related cognitive impairment. Nevertheless, synaptic loss is the principal correlate of disease progression and loss of cholinergic neurons contributes to memory and attention deficits. Thus, drugs that act on the cholinergic system represent a promising option to treat AD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AchE also interacts with Aβ peptide and promotes plaque formation [9].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [9]
In the citing paper
“Popular neuroprotective strategies for AD management consist of discovering small molecules with the ability to block these Aβ interactions with intracellular and extracellular targets to avoid caspase activation and the expression of proapoptotic proteins, to reduce the stress kinase signaling cascades, to inhibit tau protein phosphorylation, to counterpoise cholinergic functional loss, and to bo”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [38]
In the citing paper
“Neuronal loss has also been related to the dysregulation of the cholinergic system and glutamatergic system (Ferreira-Vieira et al. 2016).”
From Alzheimer’s disease: Targeting the glutamatergic system (2020) · cites this paper as Ferreira-Vieira et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6)
Mesulam, M. M., Mufson, E. J., Wainer, B. H., & Levey, A. I. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90108-2 · Cited by 2,329
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,506
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,491
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067589 · Cited by 1,437
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Identification of a Family of Muscarinic Acetylcholine Receptor Genes
Bonner, T. I., Buckley, N. J., Young, A. C., & Brann, M. R. (1987) · Science · doi:10.1126/science.3037705 · Cited by 1,423
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
CENTRAL CHOLINERGIC SYSTEMS AND COGNITION
Everitt, B. J., & Robbins, T. W. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.649 · Cited by 1,348
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000159740.16984.3c · Cited by 1,329
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
Bowen, D. M., Smith, C. B., White, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,313
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Pirenzepine distinguishes between different subclasses of muscarinic receptors
Hammer, R., Berrie, C. P., Birdsall, N. J. M., Burgen, A. S. V., & Hulme, E. C. (1980) · Nature · doi:10.1038/283090a0 · Cited by 1,273
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Sleep Cycle Oscillation: Reciprocal Discharge by Two Brainstem Neuronal Groups
Hobson, J. A., McCarley, R. W., & Wyzinski, P. (1975) · Science · doi:10.1126/science.1094539 · Cited by 1,238
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050
Voltage-clamp analysis of muscarinic excitation in hippocampal neurons
Halliwell, J. V., & Adams, P. R. (1982) · Brain Research · doi:10.1016/0006-8993(82)90954-4 · Cited by 1,046
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Fischer, W., Wictorin, K., Björklund, A., Williams, L., Varon, S. S., & Gage, F. H. (1987) · Nature · doi:10.1038/329065a0 · Cited by 1,024
Armstrong, D. M., Saper, C. B., Levey, A. I., Wainer, B. H., & Terry, R. D. (1983) · The Journal of Comparative Neurology · doi:10.1002/cne.902160106 · Cited by 970
The central cholinergic system studied by choline acetyltransferase immunohistochemistry in the cat
Kimura, H., McGeer, P. L., Peng, J. H., & McGeer, E. G. (1981) · The Journal of Comparative Neurology · doi:10.1002/cne.902000202 · Cited by 966
Cholinergic systems in mammalian brain and spinal cord
WOOLF, N. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90006-m · Cited by 948
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R. G. F., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Levey, A. I., Kitt, C. A., Wf, S., Price, D., & Brann, M. R. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-10-03218.1991 · Cited by 920
Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898
Efferent connections and nigral afferents of the nucleus accumbens septi in the rat
Nauta, W. J. H., Smith, G. P., Faull, R. L. M., & Domesick, V. B. (1978) · Neuroscience · doi:10.1016/0306-4522(78)90041-6 · Cited by 876
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Arendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782
Raina, P., Santaguida, P., Ismaila, A., Patterson, C., Cowan, D., Levine, M., Booker, L., & Oremus, M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00009 · Cited by 771
Wood, J. G., Mirra, S. S., Pollock, N. J., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4040 · Cited by 763
Nicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762
Houser, C. R., Crawford, G. D., Barber, R. P., Salvaterra, P. M., & Vaughn, J. E. (1983) · Brain Research · doi:10.1016/0006-8993(83)91312-4 · Cited by 748
The mechanism of excitation by acetylcholine in the cerebral cortex
Krnjević, K., Pumain, R., & Renaud, L. P. (1971) · The Journal of Physiology · doi:10.1113/jphysiol.1971.sp009467 · Cited by 708
Current issues in organophosphate toxicology
Costa, L. G. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.008 · Cited by 700
Bodick, N. C., Offen, W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 697
Nicotinic acetylcholine involvement in cognitive function in animals
Levin, E. D., & Simon, B. B. (1998) · Psychopharmacology · doi:10.1007/s002130050667 · Cited by 675
Cognitive functions of cortical acetylcholine: toward a unifying hypothesis
Sarter, M. F., & Bruno, J. P. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00009-4 · Cited by 675
Waldemar, G., Dubois, B., Emre, M., Georges, J., McKeith, I. G., Rossor, M. N., Scheltens, P., Tariska, P., & Winblad, B. G. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01605.x · Cited by 634
Choline, an essential nutrient for humans
Zeisel, S. H., da Costa, K.-A., Franklin, P. D., ALEXANDER, E. A., LaMont, J. T., Sheard, N. F., & Beiser, A. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.7.2010061 · Cited by 623
Metherate, R., Cox, C. L., & Ashe, J. H. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-12-04701.1992 · Cited by 575
Hamani, C., Aziz, T. Z., Bloem, B. R., Brown, P., Chabardès, S., Coyne, T. J., Foote, K. D., García‐Rill, E., Hirsch, É. C., Lozano, A. M., et al. (2016) · Stereotactic and Functional Neurosurgery · doi:10.1159/000449010 · Cited by 571
Buxbaum, J. D., Oishi, M., Chen, H. I., Pinkas‐Kramarski, R., JAFFE, E. A., Gandy, S., & Greengard, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10075 · Cited by 563
SZE, C.-I., TRONCOSO, J. C., KAWAS, C., MOUTION, P., PRICE, D. L., & MARTIN, L. J. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00011 · Cited by 562 · cited 1×
“In fact, the memory deficit and neuropathology severity observed in patients exhibiting AD highly correlate with changes in hippocampal synaptic transmission, especially with changes in synaptophysin expression, a presynaptic vesicle protein [220-222].”
BackgroundLuetje, C., & Patrick, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-03-00837.1991 · Cited by 558
ACETYLCHOLINE METABOLISM OF A SYMPATHETIC GANGLION
Birks, R. I., & MacIntosh, F. C. (1961) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o61-081 · Cited by 555
Wilcock, G. K., Esiri, M. M., Bowen, D. M., & Smith, C. C. T. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90045-4 · Cited by 553
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 548
Rye, D. B., Saper, C. B., Lee, H. J., & Wainer, B. H. (1987) · The Journal of Comparative Neurology · doi:10.1002/cne.902590403 · Cited by 545
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Synapse · doi:10.1002/syn.890160105 · Cited by 521
Voytko, M., Olton, D., Richardson, R., Gorman, L. K., Tobin, J., & Price, D. L. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00167.1994 · Cited by 520
Muscarinic acetylcholine receptors: signal transduction through multiple effectors
Felder, C. C. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768353 · Cited by 508
Hall, Z. W. (1973) · Journal of Neurobiology · doi:10.1002/neu.480040404 · Cited by 508
Voltage clamp analysis of cholinergic action in the hippocampus
Madison, D. V., Lancaster, B., & Nicoll, R. A. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-03-00733.1987 · Cited by 503
Mechanisms of action of acetylcholine in the guinea‐pig cerebral cortex in vitro.
McCormick, D. A., & Prince, D. A. (1986) · The Journal of Physiology · doi:10.1113/jphysiol.1986.sp016112 · Cited by 499
Bolam, J. P., Wainer, B. H., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90165-9 · Cited by 485
Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Jönhagen, M. E., Nordberg, A. K., Amberla, K., Bäckman, L., Ebendal, T., Meyerson, B. A., Olson, L., Seiger, Å., Shigeta, M., Theodorsson, E., et al. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017069 · Cited by 472
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor
Cooper, E., Couturier, S., & Ballivet, M. (1991) · Nature · doi:10.1038/350235a0 · Cited by 470
Dunnett, S. B., Everitt, B. J., & Robbins, T. W. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90061-x · Cited by 467
de Paula, V. D. J. R., Radanovic, M., Diniz, B. S., & Forlenza, O. V. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_14 · Cited by 466
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
Rogawski, M. A., & Wenk, G. L. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00254.x · Cited by 449
Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans
Davis, K. L., Mohs, R. C., Tinklenberg, J. R., Pfefferbaum, A., Hollister, L. E., & Kopell, B. S. (1978) · Science · doi:10.1126/science.351807 · Cited by 442
Acetylcholine Liberation from Cerebral Cortex during Paradoxical (REM) Sleep
Jasper, H. H., & Tessier, J. (1971) · Science · doi:10.1126/science.172.3983.601 · Cited by 434
SODIUM‐DEPENDENT, HIGH AFFINITY CHOLINE UPTAKE
Kuhar, M. J., & Murrin, L. C. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb07029.x · Cited by 424
M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice
Caccamo, A., Oddo, S., Billings, L. M., Green, K. N., Martinez-Coria, H., Fisher, A., & LaFerla, F. M. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.020 · Cited by 417
A Structural Motif of Acetylcholinesterase That Promotes Amyloid β-Peptide Fibril Formation
Ferrari, G. V. D., Canales, M. A., Shin, I., Weiner, L. M., Silman, I., & Inestrosa, N. C. (2001) · Biochemistry · doi:10.1021/bi0101392 · Cited by 415
Oda, Y. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00977.x · Cited by 403
Cholinesterase is associated with the basal lamina at the neuromuscular junction
McMahan, U. J., Sanes, J. R., & Marshall, L. M. (1978) · Nature · doi:10.1038/271172a0 · Cited by 400
Erickson, J. D., Varoqui, H., Schäfer, M. K.-H., Modi, W. S., Diebler, M. F., Weihe, E., Rand, J. B., Eiden, L. E., Bonner, T. I., & Usdin, T. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31734-9 · Cited by 394
Choline: an essential nutrient for humans
Zeisel, S. H. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00349-x · Cited by 392
Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · PubMed · Cited by 392
Cholinergic modulation of the functional organization of the cat visual cortex
Sillito, A. M., & Kemp, J. A. (1983) · Brain Research · doi:10.1016/0006-8993(83)90015-x · Cited by 387
Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease
Mesulam, M. M. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23415 · Cited by 382
The Caenorhabditis elegans unc-17 Gene: a Putative Vesicular Acetylcholine Transporter
Alfonso, A., Grundahl, K. M., Duerr, J. S., Han, H. P., & Rand, J. B. (1993) · Science · doi:10.1126/science.8342028 · Cited by 378
Synthesis, storage and release of [14C]acetylcholine in isolated rat diaphragm muscles
Potter, L. T. (1970) · The Journal of Physiology · doi:10.1113/jphysiol.1970.sp009003 · Cited by 359
Acetylcholine, Aging, and Alzheimer's Disease
Muir, J. L. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00431-5 · Cited by 357
Kubo, T., Maeda, A., Sugimoto, K., et al. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81144-9 · Cited by 344
Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W., & Lester, R. A. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05747.1997 · Cited by 332
THE FORMATION OF ACETYLCHOLINE. A NEW ENZYME: "CHOLINE ACETYLASE"
Nachmansohn, D. A., & Machado, A. L. (1943) · Journal of Neurophysiology · doi:10.1152/jn.1943.6.5.397 · Cited by 331
Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex
Jones, B. E. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45011-5 · Cited by 304
Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?
Rosenberg, P. B., Nowrangi, M. A., & Lyketsos, C. G. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.05.005 · Cited by 302
3 Regulation of ligand-gated ion channels by protein phosphorylation
Swope, S. L., Moss, S. J., Raymond, L. A., & Huganir, R. L. (1999) · Advances in second messenger and phosphoprotein research · doi:10.1016/s1040-7952(99)80005-6 · Cited by 299
Quaternary structure of the acetylcholine receptor
Brisson, A., & Unwin, P. N. T. (1985) · Nature · doi:10.1038/315474a0 · Cited by 286
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
Conn, P. J., Jones, C. K., & Lindsley, C. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.002 · Cited by 286
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease
Farlow, M. R., Arnold, S. E., van Dyck, C. H., Aisen, P. S. S., Snider, B. J., Porsteinsson, A. P., Friedrich, S. W., Dean, R. A., Gonzales, C., Sethuraman, G., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.224 · Cited by 285
Muir, J. L., Dunnett, S. B., Robbins, T. W., & Everitt, B. J. (1992) · Experimental Brain Research · doi:10.1007/bf00229886 · Cited by 280
“Is dopamine involved in Alzheimer's disease?”
Martorana, A., & Koch, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00252 · Cited by 276
Nicotinic Stimulation Produces Multiple Forms of Increased Glutamatergic Synaptic Transmission
Radcliffe, K. A., & Dani, J. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07075.1998 · Cited by 271
Regulation of Acetylcholine Synthesis in the Brain
Tuček, S. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07106.x · Cited by 270
Levey, A. I., Armstrong, D. M., Atweh, S., Terry, R. D., & Wainer, B. (1983) · Journal of Neuroscience · doi:10.1523/jneurosci.03-01-00001.1983 · Cited by 268
Baghdoyan, H. A., Rodrigo‐Angulo, M. L., McCarley, R. W., & Hobson, J. A. (1984) · Brain Research · doi:10.1016/0006-8993(84)90354-8 · Cited by 266
Aβ Species Removal After Aβ 42 Immunization
Nicoll, J. A. R., Barton, E., Boche, D., Neal, J. W., Ferrer, I., Thompson, P., Vlachouli, C., Wilkinson, D., Bayer, A., Games, D., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240466.10758.ce · Cited by 265
Clarke, P. B. S., & Reuben, M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15232.x · Cited by 262
Muscarinic cholinergic influences in memory consolidation
Power, A. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00086-8 · Cited by 261
van der Zee, E. A., & Luiten, P. G. M. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00092-6 · Cited by 261
Berg, L., McKeel, D. W., Miller, J. P., Baty, J., & Morris, J. C. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540040011008 · Cited by 257
Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease
Ferrante, R. J., Beal, M. F., Kowall, N. W., Richardson, E. P., & Martin, J. B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90694-9 · Cited by 257
Mrzljak, L., Levey, A. I., & Goldman-Rakic, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5194 · Cited by 256
Cholinergic modulation of cortical associative memory function
Hasselmo, M. E., Anderson, B. P., & Bower, J. M. (1992) · Journal of Neurophysiology · doi:10.1152/jn.1992.67.5.1230 · Cited by 250
Jones, C. K., Brady, A. E., Davis, A. A., Xiang, Z., Bubser, M., Tantawy, M. N., Kane, A. S., Bridges, T. M., Kennedy, J. P., Bradley, S. R., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1850-08.2008 · Cited by 248
Prado, V. F., Martins-Silva, C., de Castro, B. M., Lima, R. F., Barros, D. M., Amaral, E., Ramsey, A. J., Sotnikova, T. D., Ramirez, M. R., Kim, H.-G., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.005 · Cited by 246
Shirey-Rice, J. K., Brady, A. E., Jones, P. J., Davis, A. A., Bridges, T. M., Kennedy, J. P., Jadhav, S. B., Menon, U. N., Xiang, Z., Watson, M. L., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3930-09.2009 · Cited by 237
Dopaminergic and cholinergic lesions in progressive supranuclear palsy
Ruberg, M., Javoy-Agid, F., Hirsch, É. C., Scatton, B., L'Heureux, R., Hauw, J., Duyckaerts, C. J., Gray, F., Morel-Maroger, A., Rascol, A., et al. (1985) · Annals of Neurology · doi:10.1002/ana.410180503 · Cited by 223
Presynaptic inhibitory action of acetylcholine in area CA1 of the hippocampus
Hounsgaard, J. (1978) · Experimental Neurology · doi:10.1016/0014-4886(78)90284-4 · Cited by 221
Woolf, N. J., & Butcher, L. L. (1981) · Brain Research Bulletin · doi:10.1016/0361-9230(81)90004-6 · Cited by 221
Vesicular Localization and Activity-Dependent Trafficking of Presynaptic Choline Transporters
Ferguson, S. M., Savchenko, V. L., Apparsundaram, S., Zwick, M., Wright, J., Heilman, C. J., Yi, H. L., Levey, A. I., & Blakely, R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09697.2003 · Cited by 218
Rivastigmine Transdermal Patch
Dhillon, S. (2011) · Drugs · doi:10.2165/11206380-000000000-00000 · Cited by 215
Counts, S., Nadeem, M., Lad, S. P., Wuu, J., & Mufson, E. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00007 · Cited by 212
The cholinergic innervation of the human cerebral cortex.
Mesulam, M.-M. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)45004-8 · Cited by 211
Eiden, L. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062227.x · Cited by 209
Cholinergic modulation of the cortical neuronal network
Lucas-Meunier, E., Fossier, P., Baux, G., & Amar, M. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-002-0999-2 · Cited by 207
Nicotinic Modulation of Glutamate and GABA Synaptic Transmission in Hippocampal Neurons
RADCLIFFE, K. A., FISHER, J. L., GRAY, R., & DANI, J. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11332.x · Cited by 205
Bucci, D. J., Holland, P. C., & Gallagher, M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-08038.1998 · Cited by 204
Brady, A. E., Jones, C. K., Bridges, T. M., Kennedy, J. P., Thompson, A. D., Heiman, J. U., Breininger, M. L., Gentry, P. R., Yin, H., Jadhav, S. B., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140350 · Cited by 204
Toyoshima, C., & Unwin, N. C. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.6.2623 · Cited by 198
Acetylcholine hyperpolarizes central neurones by acting on an M2 muscarinic receptor
Egan, T. M., & North, R. A. (1986) · Nature · doi:10.1038/319405a0 · Cited by 197
Wong, T. P., Debeir, T., Duff, K., & Cuello, A. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02706.1999 · Cited by 196
Potentiation of nicotinic receptor response by external calcium in rat central neurons
Mulle, C., Léna, C., & Changeux, J. (1992) · Neuron · doi:10.1016/0896-6273(92)90208-u · Cited by 196
ALZHEIMER-LIKE CHOLINERGIC DEFICIENCY IN DOWN SYNDROME
Yates, C. M., Simpson, J., Maloney, A. F. J., Gordon, A., & Reid, A. H. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92137-6 · Cited by 190
Nakajima, Y., Nakajima, S., Leonard, R. J., et al. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.3022 · Cited by 186
Li, Y., Camp, S., Rachinsky, T. L., et al. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54466-5 · Cited by 185
Dajas‐Bailador, F., Lima, P. A., & Wonnacott, S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00127-1 · Cited by 182
The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration
O'Neill, M., Murray, T., Lakics, V., Visanji, N. P., & Duty, S. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339166 · Cited by 181
Bejanin, S., Cervini, R., Mallet, J. J., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31738-6 · Cited by 180
Molecular cloning of a putative vesicular transporter for acetylcholine.
Roghani, A., Feldman, J. D., Kohan, S. A., Shirzadi, A., Gundersen, C. B., Brecha, N. C., & Edwards, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10620 · Cited by 180
Impulse-flow regulation of high affinity choline uptake in brain cholinergic nerve terminals
Simon, J. R., & Kuhar, M. J. (1975) · Nature · doi:10.1038/255162a0 · Cited by 180
Anderson, D. C., King, S. C., & Parsons, S. M. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14413-1 · Cited by 179
Rasmusson, D. D., & Dykes, R. W. (1988) · Experimental Brain Research · doi:10.1007/bf00248353 · Cited by 177
A subcortico-cortical cholinergic system is affected in Parkinson's disease
Dunois, B., Ruberg, M., Javoy-Agid, F., Ploska, A., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90096-3 · Cited by 175
Cholinergic systems mediate action from movement to higher consciousness
Woolf, N. J., & Butcher, L. L. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.046 · Cited by 173
Fitzjohn, S. M., Morton, R. A., Kuenzi, F., Rosahl, T. W., Shearman, M., Lewis, H., Smith, D., Reynolds, D. S., Davies, C. H., Collingridge, G. L., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04691.2001 · Cited by 168
Jeon, J., Dencker, D., Wörtwein, G., Woldbye, D. P. D., Cui, Y., Davis, A. A., Levey, A. I., Schütz, G., Sager, T. N., Mørk, A., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3843-09.2010 · Cited by 168
Weinberger, N. M. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00072-8 · Cited by 165
Ferguson, S. M., Bazalakova, M. H., Savchenko, V. L., Tapia, J. C., Wright, J., & Blakely, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401667101 · Cited by 163
Distinction between Acetylcholine-Esterase and Other Choline Ester-splitting Enzymes
Augustinsson, K., & Nachmansohn, D. A. (1949) · Science · doi:10.1126/science.110.2847.98 · Cited by 162
Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats
Felix, R. A., & Levin, E. D. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00224-8 · Cited by 160
An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission
Shirey-Rice, J. K., Xiang, Z., Orton, D., Brady, A. E., Johnson, K. A., Williams, R. D., Ayala, J. E., Rodriguez, A. L., Wess, J., Weaver, D., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.55 · Cited by 160
Markram, H., & Segal, M. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019015 · Cited by 156
Molecular biology of the vesicular ACh transporter
Usdin, T. B., Eiden, L. E., Bonner, T. I., & Erickson, J. D. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93906-e · Cited by 155
A reappraisal of the functions of the nucleus basalis of Meynert
Richardson, R. T., & DeLong, M. R. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90107-5 · Cited by 154
Charpantier, E., Wiesner, A., Huh, K.-H., Ogier, R., Hoda, J., Allaman, G., Raggenbass, M., Feuerbach, D., Bertrand, D., & Fuhrer, C. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3497-05.2005 · Cited by 152
SYNTHESIS AND RELEASE OF [14C]ACETYLCH0LINE IN SYNAPTOSOMES
Haga, T. (1971) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1971.tb12008.x · Cited by 151
Acute and chronic nicotine effects on working memory in aged rats
Levin, E. D., & Torry, D. J. (1996) · Psychopharmacology · doi:10.1007/bf02246285 · Cited by 150
Winters, B. D., & Bussey, T. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04055.x · Cited by 149
Mogg, A. J., Whiteaker, P., McIntosh, J. M., Marks, M. J., Collins, A. C., & Wonnacott, S. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.197 · Cited by 146
Muscarine affects calcium-currents in rat hippocampal pyramidal cells in vitro
Gähwiler, B. H., & Brown, D. A. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90419-8 · Cited by 141
Paez-Gonzalez, P., Asrican, B., Rodriguez, E., & Kuo, C. T. (2014) · Nature Neuroscience · doi:10.1038/nn.3734 · Cited by 140
The amyloid pathology progresses in a neurotransmitter-specific manner
Bell, K. F. S., Ducatenzeiler, A., Ribeiro‐da‐Silva, A., Duff, K., Bennett, D. A., & Cuello, A. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.034 · Cited by 139
Response of the hypothalamo-pituitary-adrenal axis to nicotine
Matta, S. G., Fu, Y., Valentine, J. D., & Sharp, B. M. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00079-6 · Cited by 139
Seiger, Å., Nordberg, A. K., von Holst, H., Bäckman, L., Ebendal, T., Alafuzoff, I. I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., et al. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90141-c · Cited by 139
Rat hippocampal neurons in culture: responses to electrical and chemical stimuli
Segal, M. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.50.6.1249 · Cited by 139
Fine, A., Hoyle, C., Maclean, C. J., LeVatte, T. L., Baker, H. F., & Ridley, R. M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00208-x · Cited by 138
Kish, S. J., El‐Awar, M., Schut, L. J., Leach, L. R., Oscar‐Berman, M., & Freedman, M. (1988) · Annals of Neurology · doi:10.1002/ana.410240205 · Cited by 138
Wenk, G. L., Parsons, C. G., & Danysz, W. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00007 · Cited by 134
Roberts, W. L., Kim, B. H., & Rosenberry, T. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.7817 · Cited by 132
Cholinergic modulation of sensory responses in rat primary somatic sensory cortex
Donoghue, J. P., & Carroll, K. L. (1987) · Brain Research · doi:10.1016/0006-8993(87)90407-0 · Cited by 127
Janowsky, D. S., & Risch, S. C. (1984) · Drug Development Research · doi:10.1002/ddr.430040202 · Cited by 126
Brioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., & Cowart, M. (2010) · Cited by 125
Misawa, H., Ishii, K., & Deguchi, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88714-8 · Cited by 124
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A antibody
Bales, K. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27120 · Cited by 123
A multiplicity of muscarinic mechanisms: Enough signaling pathways to take your breath away
Nathanson, N. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6245 · Cited by 121
Alzheimer’s Disease and the Aging Brain
Terry, R. D. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291079 · Cited by 118
Apelt, J., Kumar, A., & Schliebs, R. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03262-6 · Cited by 117
Kim, J. S., & Levin, E. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00213-2 · Cited by 115
Bahr, B. A., & Parsons, S. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2267 · Cited by 115
Alternative Splicing Leads to Two Cholinergic Proteins in Caenorhabditis elegans
Alfonso, A., Grundahl, K. M., McManus, J. R., Asbury, J. M., & Rand, J. B. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1538 · Cited by 114
Tubular crystals of acetylcholine receptor.
Brisson, A., & Unwin, P. N. T. (1984) · The Journal of Cell Biology · doi:10.1083/jcb.99.4.1202 · Cited by 112
Miranda, M. I., & Bermúdez‐Rattoni, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6478 · Cited by 109
Rogers, J. L., & Kesner, R. P. (2004) · Learning & Memory · doi:10.1101/lm.64604 · Cited by 107
Slow Excitotoxicity in Alzheimer's Disease
Ong, W.-Y., Tanaka, K., Dawe, G. S., Ittner, L. M., & Farooqui, A. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121990 · Cited by 106
Storage of dopamine and acetylcholine in granules of PC12, a clonal pheochromocytoma cell line
Rebois, R. V., Reynolds, E. E., Toll, L., & Howard, B. D. (1980) · Biochemistry · doi:10.1021/bi00547a031 · Cited by 106
Distribution of the high-affinity choline transporter in the central nervous system of the rat
Misawa, H., Nakata, K., Matsuura, J., Nagao, M., Okuda, T., & Haga, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00147-6 · Cited by 105
Deterministic functions of cortical acetylcholine
Sarter, M. F., Lustig, C., Howe, W. M., Gritton, H. J., & Berry, A. S. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12515 · Cited by 104
Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes
Wilkie, G., Hutson, P. H., Sullivan, J. P., & Wonnacott, S. (1996) · Neurochemical Research · doi:10.1007/bf02532425 · Cited by 103
Cloning and expression of the vesamicol binding protein from the marine ray Torpedo
Varoqui, H., Diebler, M., Meunier, F.-M., Rand, J. B., Usdin, T. B., Bonner, T. I., Eiden, L. E., & Erickson, J. D. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80592-x · Cited by 102
Krantz, D. E., Waites, C. L., Oorschot, V. M. J., Liu, Y., Wilson, R. I., Tan, P. K., Klumperman, J., & Edwards, R. H. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.2.379 · Cited by 100
Maulet, Y., Camp, S., Gibney, G., Rachinsky, T. L., Ekströ, T. J., & Taylor, P. (1990) · Neuron · doi:10.1016/0896-6273(90)90103-m · Cited by 98
Structure and Organization of the DrosophilaCholinergic Locus
Kitamoto, T., Wang, W., & Salvaterra, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2706 · Cited by 94
Wang, B., Yang, L., Wang, Z., & Zheng, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704070104 · Cited by 94
One Hundred Years after the Discovery of Alzheimer's Disease. A Turning Point for Therapy?
Giacobini, E., & Becker, R. E. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12105 · Cited by 92
Tsang, S. W. Y., Lai, M. K. P., Kirvell, S. L., Francis, P. T., Esiri, M. M., Hope, T., Chen, C., & Wong, P. T. ‐. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.010 · Cited by 92
Boccia, M. M., Acosta, G. B., Blake, M. G., & Baratti, C. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.001 · Cited by 90
M1 muscarinic receptor signaling in mouse hippocampus and cortex
Porter, A. C., Bymaster, F. P., DeLapp, N. W., Yamada, M., Wess, J., Hamilton, S. E., Nathanson, N. M., & Felder, C. C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02721-x · Cited by 90
Aquilonius, S., Eckernäs, S. ‐., & Sundwall, A. (1975) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.38.7.669 · Cited by 90
Vickroy, T. W., Roeske, W. R., Gehlert, D. R., Wamsley, J. K., & Yamamura, H. I. (1985) · Brain Research · doi:10.1016/0006-8993(85)90553-0 · Cited by 89
Rapid Upregulation of α7 Nicotinic Acetylcholine Receptors by Tyrosine Dephosphorylation
Cho, C.-H., Song, W., Leitzell, K., Teo, E., Meleth, A. D., Quick, M. W., & Lester, R. A. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5389-03.2005 · Cited by 87
Research works printed but not linked: 1
- [1]Loewi O. Über humerole übertragbarkeit der herznervenwirkung. I Mitteilung Pflugers Arch., 1921, 189, 239-242. 10. 1007/BF01738910 1921
Cited by
Sorted by citations
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Basso, J. C., & Suzuki, W. A. (2016) · Brain Plasticity · doi:10.3233/bpl-160040 · Cited by 911
Chen, Y., Xu, J., & Chen, Y. (2021) · Nutrients · doi:10.3390/nu13062099 · Cited by 917
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
“AchE also interacts with Aβ peptide and promotes plaque formation [9].”
Background
Metadata
- Authors
- H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F.
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2016-01-22
- Volume
- 14
- Issue
- 1
- Pages
- 101-115
- ISSN
- 1570-159X (ISSN-L)
- PMC
- PMC4787279
- OpenAlex
- W2261085470
- Cited by
- 1,551
- References
- 277
- Citations by year
- 2026: 120 · 2025: 191 · 2024: 207 · 2023: 224 · 2022: 224 · 2021: 214 · 2020: 173 · 2019: 108 · 2018: 44 · 2017: 35 · 2016: 8
- FWCI
- 52.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc
- Locations
- Current Neuropharmacology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, cholinergic system, acetylcholine, choline acetyltransferase, vesicular acetylcholine transporter, acetylcholinesterase, choline transporter 1, muscarinic receptors, nicotinic acetylcholine receptors, cholinergic neurons, nucleus basalis of Meynert, synaptic loss, acetylcholinesterase inhibitors, cholinergic drugs
- MeSH terms
- Acetylcholine, Alzheimer Disease, Animals, Cholinesterase Inhibitors, Humans, Receptors, Cholinergic, Drug Delivery Systems, Cholinergic Agents, Cholinergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review